EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic insights and in vivo efficacy of thiosemicarbazones against methicillin-resistant Staphylococcus aureus

Avery Gaudreau, David W Watson, Ronald S Flannagan, Paroma Roy, Chenfangfei Shen, Ahmed Abdelmoneim, William N Beavers, Elizabeth R Gillies, Omar M El-Halfawy, David E Heinrichs

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Avery Gaudreau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, The University of Western Ontario, London, Ontario, Canada. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Thiosemicarbazones, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Canada Research Chairs, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus poses a significant threat in both community and hospital settings due to its infective and pathogenic nature combined with its ability to resist the action of chemotherapeutic agents. Methicillin-resistant S. aureus (MRSA) represents a critical challenge. Metal-chelating thiosemicarbazones (TSCs) have shown promise in combating MRSA and while previous studies hinted at the antimicrobial potential of TSCs, their mechanisms of action against MRSA are still under investigation. We screened a chemical library for anti-staphylococcal compounds and identified a potent molecule named R91 that contained the NNSN structural motif found within TSCs. We identified that R91 and several structural analogs exhibited antimicrobial activity against numerous S. aureus isolates as well as other Gram-positive bacteria. RNAseq analysis revealed that R91 induces copper and oxidative stress responses. Checkerboard assays demonstrated synergy of R91 with copper, nickel, and zinc. Mutation of the SrrAB two-component regulatory system sensitizes S. aureus to R91 killing, further linking the oxidative stress response to R91 resistance. Moreover, R91 was found to induce hydrogen peroxide production, which contributed to its antimicrobial activity. Remarkably, no mutants with elevated R91 resistance were identified, despite extensive attempts. We further demonstrate that R91 can be used to effectively treat an intracellular reservoir of S. aureus in cell culture and can reduce bacterial burdens in a murine skin infection model. Combined, these data position R91 as a potent TSC effective against MRSA and other Gram-positive bacteria, with implications for future therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusThiosemicarbazonesAnti-Bacterial AgentsMicrobial Sensitivity TestsAnimalsMiceStaphylococcal InfectionsHumansOxidative StressCopperFemaleBacterial Proteins

Stichwörter der Autor:innen

MOAMRSAS. aureusantibioticinfection modelthiosemicarbazones

Substanzen

ThiosemicarbazonesAnti-Bacterial AgentsCopperBacterial Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, The University of Western Ontario, London, Ontario, Canada.
  • Department of Chemistry, The University of Western Ontario, London, Ontario, Canada.
  • Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA; Louisiana Animal Disease Diagnostic Laboratory, Louisiana State University, Baton Ro…
  • Department of Pathobiological Sciences, Louisiana State University School of Veterinary Medicine, Baton Rouge, Louisiana, USA.
  • Department of Chemistry, The University of Western Ontario, London, Ontario, Canada; Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, Ontario, Canada.
  • Department of Chemistry and Biochemistry, University of Regina, Regina, Saskatchewan, Canada; Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

Förderung

  • NIAID NIH HHS
  • Canada Research Chairs
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada
  • Saskatchewan Health Research Foundation
  • McMaster University

Zitieren

APA

Gaudreau, A., Watson, D. W., Flannagan, R. S., Roy, P., Shen, C., Abdelmoneim, A., Beavers, W. N., Gillies, E. R., El-Halfawy, O. M., & Heinrichs, D. E. (2024). Mechanistic insights and in vivo efficacy of thiosemicarbazones against methicillin-resistant Staphylococcus aureus. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107689

Vancouver

Gaudreau A, Watson DW, Flannagan RS, Roy P, Shen C, Abdelmoneim A, et al. Mechanistic insights and in vivo efficacy of thiosemicarbazones against methicillin-resistant Staphylococcus aureus. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107689

BibTeX
@article{Gaudreau2024,
  author = {Gaudreau, Avery and Watson, David W and Flannagan, Ronald S and Roy, Paroma and Shen, Chenfangfei and Abdelmoneim, Ahmed and Beavers, William N and Gillies, Elizabeth R and El-Halfawy, Omar M and Heinrichs, David E},
  title = {Mechanistic insights and in vivo efficacy of thiosemicarbazones against methicillin-resistant Staphylococcus aureus},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107689}
}
Kostenlos starten →